Skip to search formSkip to main content

n-(n-nonyl)-deoxygalactonojirimycin

Known as: n-(n-nonyl)-deoxygalacto-nojirimycin 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
II3NeuAc-GgOse4Cer (GM1) gangliosidosis is an incurable lysosomal storage disease caused by a deficiency in acid beta… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 4
Is this relevant?
1999
1999
Novel lipophilic and neutral glucose analogs, which are potentially useful for tumor imaging, have been developed. They are… Expand
Is this relevant?
1996
1996
The antimetastatic activity of ten compounds structurally related to nojirimycin A was examined using a pulmonary metastatic… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
1989
1989
Castanospermine-glucosides (CS-glcs) are new compounds which have been evaluated as glycohydrolase inhibitors in rats. 7-O-alpha… Expand
Is this relevant?
1984
1984
A new aminosugar named nojirimycin B (1) has been isolated as its bisulfite adduct from the culture broth of Streptomyces… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
1984
1984
Summarythe effect of N-methyl-1-deoxy-nojirimycin (NMDN; 1,5-dideoxy-1,5-imino-N-methyl-D-glucit) was studied with crude extracts… Expand
  • figure 1
  • figure 2
  • figure 3
Is this relevant?